C. Cooper

发表

Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques

M. Girolami, C. Cooper, L. Carrivick, 2006, Journal of The Royal Society Interface.

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

J Cuzick, L Ambroisine, W. Gerald, 2008, Oncogene.

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

S. Vowler, J. Lindberg, H. Grönberg, 2015, EBioMedicine.

BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas

R. Eeles, M. Dyer, C. Cooper, 1999, British Journal of Cancer.

High-density tissue microarrays from prostate needle biopsies

S. Jhavar, C. Cooper, P. Flohr, 2010, Journal of Clinical Pathology.

Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.

B. Gusterson, C. Fisher, H. Jayatilake, 1994, British Journal of Cancer.

[Breast cancer in the early stage].

R. J. Jones, M. Espié, G. Giaccone, 2012, Gan no rinsho. Japan journal of cancer clinics.

Cytogenetic and molecular analysis of synovial sarcoma.

B. Gusterson, J. Clark, C. Cooper, 1992, International journal of oncology.

Cytogenetic abnormalities in human ependymomas

M. Stratton, C. Cooper, P. Lantos, 1989, International journal of cancer.

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

J. Cuzick, D. Berney, P. Scardino, 2009, British Journal of Cancer.

Complex patterns of ETS gene alteration arise during cancer development in the human prostate

J. Cuzick, D. Berney, P. Scardino, 2008, Oncogene.

Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling

R. Wooster, C. Fisher, J. Clark, 2003, British Journal of Cancer.

Hormone-sensitive prostate cancer: a case of ETS gene fusion heterogeneity

D. Dearnaley, C. Parker, C. Cooper, 2008, Journal of Clinical Pathology.

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer

J. Cuzick, D. Berney, I. Mills, 2008, British Journal of Cancer.

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

R. Eeles, A. Thompson, T. Christmas, 2007, Oncogene.

The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer

J. Cuzick, D. Berney, P. Scardino, 2010, Prostate Cancer and Prostatic Diseases.

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

W. Gerald, J. Cuzick, D. Berney, 2010, British Journal of Cancer.

Duplication of the fusion of TMPRSS 2 to ERG sequences identifies fatal human prostate cancer

D. Berney, P. Scardino, V. Reuter, 2009 .

Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel‐associated box in human synovial sarcoma.

B. Gusterson, C. Fisher, J. Clark, 1995, The EMBO journal.

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer

R. Eeles, S. Jhavar, A. Norman, 2008, British Journal of Cancer.

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer

J. Cuzick, D. Berney, P. Scardino, 2014, British Journal of Cancer.

Splice variant PRKC-ζ-PrC is a novel biomarker of human prostate cancer

C. Cooper, P. Smith, C. Foster, 2012, British Journal of Cancer.

Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique

C Cummings, R. Eeles, D. Dearnaley, 2005, Journal of Clinical Pathology.

radiological studies : a new whole molecularcorrelation of data from histopathological , Processing of radical prostatectomy specimens for

R. Eeles, S. Edwards, T. Christmas, 2005 .

Construction of tissue microarrays from prostate needle biopsy specimens

D. Dearnaley, S. Jhavar, C. Fisher, 2005, British Journal of Cancer.

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance

R. Eeles, A. Horwich, R. Huddart, 2009, Prostate Cancer and Prostatic Diseases.

Concepts of epigenetics in prostate cancer development

C. Cooper, C. Foster, 2008, British Journal of Cancer.

An improved method for constructing tissue microarrays from prostate needle biopsy specimens

S. Jhavar, J. Clark, C. Cooper, 2009, Journal of Clinical Pathology.

Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]

H. Ross-Adams, A.D. Lamb, M.J. Dunning, 2017, EBioMedicine.